Adjustment of N Stages of Gastric Cancer by the Ratio Between the Metastatic and Examined Lymph Nodes

被引:46
作者
Kim, Chan-Young [1 ]
Yang, Doo-Hyun [1 ]
机构
[1] Chonbuk Natl Univ, Sch Med, Dept Surg, Chonju, Chonbuk, South Korea
关键词
PROGNOSTIC-SIGNIFICANCE; TNM CLASSIFICATION; NUMBER;
D O I
10.1245/s10434-009-0430-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study attempted to determine whether N stage could be adjusted for the differences in survival rates based on the ratio between the examined and metastatic lymph nodes (LN ratio). Five hundred and twenty-nine patients with both > 15 lymph nodes examined and a parts per thousand yen N1 after R0 resection were enrolled in the present study. To determine the cutoff LN ratio, the ratios at each N stage were compared at intervals of 10% with the log-rank test of Kaplan-Meier estimates of the survival curves. The 5-year survival rate of patients with N1 was 71.7%. Those of N2 patients with LN ratio of < 60% (n = 116) and a parts per thousand yen60% (n = 3) were 37.0% and 0%, respectively. Those of N3 patients with LN ratio of < 30% (n = 32), between 30% and 60% (n = 67), and a parts per thousand yen60% (n = 26) were 31.0%, 16.3%, and 0%, respectively. Thus, adjusted N2 was obtained from the sum of N2 < 60% and N3 < 30%. N3 with an LN ratio between 30% and 60% was regarded as adjusted N3. N2 and N3 patients with an LN ratio of a parts per thousand yen60% were regarded as adjusted T4. The 5-year survival rate in patients with adjusted N2, N3, and N4 were 35.7%, 16.3%, and 0%, respectively. Multivariate analysis showed adjusted N stage and tumor depth were significant independent prognostic factors. The results of this study suggest that, since stage migration can be induced in the N staging system, such stage migration can be adjusted by the LN ratio based on the survival rate.
引用
收藏
页码:1868 / 1874
页数:7
相关论文
共 18 条
  • [1] Outcome of ratio of lymph node metastasis in gastric carcinoma
    Bando, E
    Yonemura, Y
    Taniguchi, K
    Fushida, S
    Fujimura, T
    Miwa, K
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (08) : 775 - 784
  • [2] SURGICAL PATHOLOGICAL-STAGE MIGRATION CONFOUNDS COMPARISONS OF GASTRIC-CANCER SURVIVAL RATES BETWEEN JAPAN AND WESTERN COUNTRIES
    BUNT, AMG
    HERMANS, J
    SMIT, VTHBM
    VANDEVELDE, CJH
    FLEUREN, GJ
    BRUIJN, JA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) : 19 - 25
  • [3] Prognostic impact of positive lymph node ratio in gastric carcinoma
    Celen, Orhan
    Yildirim, Emin
    Berberoglu, Ugur
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2007, 96 (02) : 95 - 101
  • [4] The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients
    de Manzoni, G
    Verlato, G
    Roviello, F
    Morgagni, P
    Di Leo, A
    Saragoni, L
    Marrelli, D
    Kurihara, H
    Pasini, F
    [J]. BRITISH JOURNAL OF CANCER, 2002, 87 (02) : 171 - 174
  • [5] Prognostic significance of the number of metastatic lymph nodes in early gastric cancer
    Gunji, Y
    Suzuki, T
    Hori, S
    Hayashi, H
    Matsubara, H
    Shimada, H
    Ochiai, T
    [J]. DIGESTIVE SURGERY, 2003, 20 (02) : 148 - 153
  • [6] PTNM AND RESIDUAL TUMOR CLASSIFICATIONS PROBLEMS OF ASSESSMENT AND PROGNOSTIC-SIGNIFICANCE
    HERMANEK, P
    [J]. WORLD JOURNAL OF SURGERY, 1995, 19 (02) : 184 - 190
  • [7] COMPARISON OF THE PROGNOSTIC-SIGNIFICANCE BETWEEN THE NUMBER OF METASTATIC LYMPH-NODES AND NODAL STAGE BASED ON THEIR LOCATION IN PATIENTS WITH GASTRIC-CANCER
    ICHIKURA, T
    TOMIMATSU, S
    OKUSA, Y
    UEFUJI, K
    TAMAKUMA, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) : 1894 - 1900
  • [8] The superiority of ratio-based lymph node staging in gastric carcinoma
    Inoue, K
    Nakane, Y
    Iiyama, H
    Sato, M
    Kanbara, T
    Nakai, K
    Okumura, S
    Yamamichi, K
    Hioki, K
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (01) : 27 - 34
  • [9] Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10
  • [10] Clinical implications of metastatic lymph node ratio in gastric cancer
    Liu, Caigang
    Lu, Ping
    Lu, Yang
    Xu, Huimian
    Wang, Shubao
    Chen, Junqing
    [J]. BMC CANCER, 2007, 7 (1)